EGCG showed promising results on prostate cancer stem cells through the inhibition of colony and spheres formation, the inhibition of EMT, the down-regulation of vimentin, Bcl-2, and survivin, and the up-regulation of caspase-3 and apoptosis induction [152]. The gene discussed is BCL2; the disease is prostate cancer.